Patents by Inventor Ludovic Drouet

Ludovic Drouet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
    Patent number: 5648100
    Abstract: The present invention concerns the use of microspheres for therapeutic embolization consisting of a hydrophilic acrylic copolymer coated with a cell adhesion promoter.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 15, 1997
    Assignees: Assistance Publique Hopitaux de Paris, BioSepra S.A.
    Inventors: Egisto Boschetti, Michel Brouard, Ludovic Drouet, Pierre Girot, Alexandre Laurent, Michel Wassef
  • Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
    Patent number: 5635215
    Abstract: The present invention concerns the use of microspheres for therapeutic embolization consisting of a hydrophilic acrylic copolymer coated with a cell adhesion promoter.
    Type: Grant
    Filed: March 29, 1994
    Date of Patent: June 3, 1997
    Assignees: BioSepra S.A., Assistance Publique Hopitaux de Paris
    Inventors: Egisto Boschetti, Michel Brouard, Ludovic Drouet, Pierre Girot, Alexandre Laurent, Michel Wassef
  • Tetra- and pentapeptides containing the lysyl-arginyl-aspartyl sequence and their applications as medicines, particularly anti-thrombotic medicines
    Patent number: 4943562
    Abstract: The peptides according to the invention are of the following general formula I:Z-Lys-Arg-Asp-X-Y (I)wherein:X is the residue of one of the 20 common aminoacids in the L-configuration,Y is hydroxyl or the C-terminal residue of one of the 20 common aminoacids in the L-configuration,Z is acetyl, hydrogen or the N-terminal residue of one of the 20 common aminoacids in the L-configuration, as the case may be N-acetylated, whereby it is understood that:when Y is the C-terminal residue of one of the 20 common aminoacids in the L-configuration, Z is acetyl or hydrogen andX can in all cases be different from Y and from Z.Application to the preparation of anti-thrombotic medicines.
    Type: Grant
    Filed: October 28, 1988
    Date of Patent: July 24, 1990
    Assignees: Institut des Vaisseaux et du Sang, Centre National de la Recherche Scientifique
    Inventors: Pierre Jolles, Anne-Marie Fiat, Claudine Soria, Levy-Toledano Sylviane, Sanghamitra Raha, Elisabeth Mazoyer, Ludovic Drouet